AbbVie Raises Annual Profit Forecast
AbbVie raised its annual profit forecast after reporting third-quarter results that beat Wall Street expectations. Strong demand for immunology and neuroscience drugs drove the growth.
Xurve View
Insights:
Xurve View
AbbVie raised its annual adjusted profit forecast to a range of $13.95 to $13.99 per share on Friday morning after topping Wall Street third-quarter expectations. The upgrade was driven by booming demand for newer immunology and neuroscience treatments, pushing shares up 1%.
